title: Vascular proteomics and the discovery process of clinical biomarkers: The case of TWEAK.
abstract: In the last years, big efforts are devoted to the search of novel biomarkers. Proteomic approaches in healthy and pathological samples may help us to discern differential protein expression patterns. These identified proteins include potential culprits in pathological pathways and/or clinical biomarkers to identify individuals at risk. However, extensively validation must be carried out before their implementation into the clinical practice. Biomarkers need to discriminate between health and disease, detect preclinical disease stages, have impact on survival prediction, and add predictive value beyond traditional risk factors and global risk algorithms. Now, we summarize the data of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK), a new cardiovascular biomarker identified by proteomic analysis. Decreased sTWEAK concentrations have been shown in patients with carotid atherosclerosis, coronary artery disease, congestive heart failure, peripheral artery disease, or chronic kidney disease (CKD). sTWEAK predicted adverse outcomes in patients with heart failure, myocardial infarction, and CKD. Finally, different drug regimens were able to modify sTWEAK plasma levels in patients with CKD. Although sTWEAK seems so far to fulfill the requisites in the development of a new biomarker, more large-scale studies are warranted to consolidate its usefulness.
authors.affiliation: Renal and Vascular Research Lab, IIS-Fundación Jimenez Díaz, Autónoma University, Madrid, Spain. lblanco@fjd.es
authors.forename: Luis M
authors.initials: LM
authors.lastname: Blanco-Colio
authors.forename: Jose L
authors.initials: JL
authors.lastname: Martín-Ventura
authors.forename: Juan J
authors.initials: JJ
authors.lastname: Carrero
authors.forename: Mahmut I
authors.initials: MI
authors.lastname: Yilmaz
authors.forename: Juan A
authors.initials: JA
authors.lastname: Moreno
authors.forename: Carmen
authors.initials: C
authors.lastname: Gómez-Guerrero
authors.forename: Alberto
authors.initials: A
authors.lastname: Ortiz
authors.forename: Jesús
authors.initials: J
authors.lastname: Egido
mesh_terms: D017209:Apoptosis; D015415:Biomarkers / Q000737:chemistry / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism* / Q000473:pathology*; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D006801:Humans; D040901:Proteomics / Q000379:methods*; D014409:Tumor Necrosis Factor-alpha / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha